You have 9 free searches left this month | for more free features.

Condition

Head Neck Cancer (1)

Metastatic Melanoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Dynavax Technologies Corporation (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

pembrolizumab (1)

sd-101(1) (1)

sd-101(2) (1)

sd-101(3) (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

sd-101(1)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated

Metastatic Melanoma
Head Neck Cancer

SD-101(1)
+3 more

Birmingham, Alabama
+46 more

Jul 12, 2021